INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 449m ago
HOUSE PTR49m ago
SEC 13F49m ago
ROBINHOOD CHAIN49m ago
SEC FORM 4/Open-market saleVerified dataRule 10b5-1 plan

Perry Jennifer Scott sold BCYC

Chief Operating Officer · BICYCLE THERAPEUTICS PLC · Ordinary Shares

Side
SELL
Value
$1,678
Shares
333
Price
$5.04
Executed
Apr 6, 2026
Disclosed
Apr 6, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Apr 6 executedApr 6, 2026 disclosed

BCYC · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
16/ 100 · ROUTINE
Methodology →
  • Transaction type+6 / 20

    Open-market sale

  • Relative size+1 / 25

    $2K reported value · 0.4% of prior position

  • Filing timing0 / 15

    Disclosed 0 business days after execution (deadline: 2)

  • Historical behavior+4 / 15

    1 prior trade recorded in this security

  • Frequency & clustering+15 / 15

    4 other actors traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BCYC

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    13
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$3,796
    1,094 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    13
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$285
    80 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    13
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$1,232
    326 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    40
    SC
    Swanton Robert CharlesDirector
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$12K
    3,431 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    29
    HF
    Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$5,455
    1,572 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    29
    TA
    Thompson Travis AlvinChief Financial Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$282
    79 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    32
    SM
    Skynner MichaelCHIEF SCIENTIFIC OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$1,796
    503 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    32
    LK
    Lee KevinDirector, CHIEF EXECUTIVE OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$21K
    6,167 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    29
    TA
    Thompson Travis AlvinChief Financial Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$3,099
    893 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    29
    HF
    Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$864
    242 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    32
    LK
    Lee KevinDirector, CHIEF EXECUTIVE OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$5,848
    1,638 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    32
    SM
    Skynner MichaelCHIEF SCIENTIFIC OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$6,739
    1,942 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    32
    SM
    Skynner MichaelCHIEF SCIENTIFIC OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$2,293
    532 sh
    		Jul 6, 2026Jul 7, 2026
    traded Jul 6, 2026
    		+1dSEC FORM 4

    Evidence

    38
    SM
    Skynner MichaelCHIEF SCIENTIFIC OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$7,938
    1,859 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    32
    LK
    Lee KevinDirector, CHIEF EXECUTIVE OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$7,486
    1,737 sh
    		Jul 6, 2026Jul 7, 2026
    traded Jul 6, 2026
    		+1dSEC FORM 4

    Evidence

    32
    TA
    Thompson Travis AlvinChief Financial Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$448
    104 sh
    		Jul 6, 2026Jul 7, 2026
    traded Jul 6, 2026
    		+1dSEC FORM 4

    Evidence

    38
    HF
    Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$6,431
    1,506 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    38
    TA
    Thompson Travis AlvinChief Financial Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$3,497
    819 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    16
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$1,445
    333 sh
    		Jul 6, 2026Jul 7, 2026
    traded Jul 6, 2026
    		+1dSEC FORM 4

    Evidence

    22
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$4,424
    1,036 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002119908-26-000005
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Apr 6, 2026
    Published
    Apr 6, 2026
    Ingested by INSIDER
    Nov 5, 04:07 UTC
    Last re-read
    Nov 5, 04:07 UTC

    Extracted facts

    Filer
    Perry Jennifer Scott
    Role
    Chief Operating Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    BICYCLE THERAPEUTICS PLC
    Ticker
    BCYC
    Shares
    333
    Price per share
    $5.04
    Value
    $1,678
    Execution date (reported)
    Apr 6, 2026
    Owned after transaction
    92.5K shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    0

    Calculation

    Value = shares × reported price per share

    • Shares: 333
    • Price: $5.04

    = $1,678

    What this establishes

    Perry Jennifer Scott filed this Form 4 reporting a open-market sale of BCYC on Apr 6, 2026. It became public on Apr 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Operating Officer
    Perry Jennifer Scottcik:0002119908
    Issuer
    BICYCLE THERAPEUTICS PLCcik:0001761612

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.